GOAL.MD review
A named, checkable physician (Dr. Michael Mimlitz, MD) backs a $199/mo semaglutide, $299/mo tirzepatide standard rate — the ads lead with a $50-off first month, but the real ongoing number sits right on the same page.
then $199/mo ongoing
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
GOAL.MD at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Nationwide, per its own site
- Brand-name
- Yes
How we scored GOAL.MD
Each score comes out of GOAL.MD's published pricing, disclosures and oversight, and the six combine into the 58/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- goal.md/weight-loss/semaglutide-injection
$199 and $299 are the standard rates; the $149 and $249 leading the marketing are $50 off, once. Both product pages name a physician whose NPI you can look up, which is a rarer kind of accountability than a certification badge. Nationwide, per its own site.
What to expect when you sign up
We walked GOAL.MD's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Each product page states the promo and standard price directly on one line
- 2Free consultation with a licensed U.S. physician
- 3Medications dispensed by licensed U.S. pharmacies
- 4Site states "No auto-billing" for the ongoing charge
What we noticed
- Medically reviewed by a named, NPI-verifiable physician: Dr. Michael Mimlitz, MD (NPI 1508891870)
- A dedicated brand-name-access page exists for manufacturer-channel medication, though no price is published there
- The ad copy leads with the first-month promo, not the standard rate — read past the first line
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $149 → $199 | Standard monthly"$149 your first month ($50 off), then $199/mo" — $199 is the standard ongoing rate. |
| Compounded tirzepatide | $249 → $299 | Standard monthly"$249 your first month ($50 off), then $299/mo" — same promo-then-standard structure. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from GOAL.MD's public disclosures at last review and change often; confirm the current number on GOAL.MD's own site.
What we like
- Names an NPI-verifiable physician rather than an anonymous clinical network
- The standard ongoing rate is disclosed on the same page as the promo
- Nationwide, plus a separate brand-name-access pathway
- States "No auto-billing" for the ongoing charge
The caveats
- Marketing leads with the promo rate, not the standard monthly price
- No price published for the brand-name-access pathway
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
GOAL.MD for mothers: our verdict
A named, checkable physician (Dr. Michael Mimlitz, MD) backs a $199/mo semaglutide, $299/mo tirzepatide standard rate — the ads lead with a $50-off first month, but the real ongoing number sits right on the same page. The advertised entry is $149, but the standing rate settles near $199/month — so read the headline as a starting offer, not the real monthly cost.
We weigh GOAL.MD the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What GOAL.MD actually costs
- Compounded semaglutide — Standard monthly: $149 to start, then $199/mo
- Compounded tirzepatide — Standard monthly: $249 to start, then $299/mo
That's roughly in line with the ~$179/month median across our roster.
The medications GOAL.MD prescribes
GOAL.MD prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. It can also route you to FDA-approved brand pens rather than only compounded vials, and those carry the manufacturer's own pregnancy and lactation labeling, which is a cleaner document to take to an OB.
Where GOAL.MD fits — and where it doesn't — for mothers
Worth it if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in GOAL.MD's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
GOAL.MD is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want a real, checkable physician's name behind the prescription and don't mind reading past a promo headline.
Alternatives to GOAL.MD
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing GOAL.MD
Head-to-head & alternatives
GOAL.MD, answered
- Is $149/mo GOAL.MD's real price?
- No — that's the first-month promo. The page itself says "then $199/mo" for semaglutide going forward (and $249 then $299 for tirzepatide).
- Does GOAL.MD offer brand-name Wegovy or Zepbound?
- It has a dedicated brand-access page for manufacturer-channel medication, but no price is published there.
Pricing, states and verification reflect GOAL.MD's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.